The antibody recognises CD2, a protein on the surface of T cells and some NK cells, which facilitates T cell adhesion and activation by interacting with CD58. CD2 is key in the immune response, and antibodies such as RPA-2.10 block associated immune functions. Disruption of CD2 is linked to immune disorders and certain cancers.